| Ding, C and Jones, G, “Belimumab Human Genome Sciences/Cambridge Antibody Technology/GlaxoSmithKline”, Current Opinion in Investigational Drugs, 7 (5) pp. 464-472. (2006) [Review Single Work] |
| Data Type | Value |
|---|
| Type of Research | Applied Research |
| Research Division | Biomedical and Clinical Sciences |
| Research Group | Clinical sciences |
| Research Field | Clinical sciences not elsewhere classified |
| Research Objective Division | Health |
| Research Objective Group | Other health |
| Research Objective Field | Other health not elsewhere classified |
| Visit Item on eCite | http://ecite.utas.edu.au/41726 |
